Reckitt Benckiser Group plc Sponsored ADR (RBGLY)
Reckitt stock dips on Q1 miss: what's really ailing the health giant?
Reckitt stock fell about 5% in early trading on Wednesday after the consumer goods group said first-quarter core like-for-like net revenue rose only 1.3%. The figure was well below the 2.9% analysts had expected, and warned that first-half adjusted operating margin would be roughly 200 basis points lower than a year earlier.
Reckitt's Like-for-Like Revenue Rises on Emerging Markets Performance
Lysol maker Reckitt Benckiser booked a rise in first-quarter like for like revenue, helped by strong emerging markets performance, where like-for-like sales grew 7.6%.
New Strong Sell Stocks for April 10th
RBGLY, SOUHY and SUNS have been added to the Zacks Rank #5 (Strong Sell) List on April 10, 2026.
Reckitt Benckiser: Cheap Again Amid Macro Concerns
Reckitt Benckiser remains a 'Buy' despite near-term macro uncertainty from the Iran War and weak consumer sentiment. RBGLY's core business has been doing fine, with solid growth in emerging markets offsetting lackluster performance in Europe. At a trailing price-to-earnings ratio of 14.5, RBGLY trades at a significant discount to U.S. peers despite strong profitability and reasonable leverage.
Reckitt Benckiser Group (OTCMKTS:RBGLY) Stock Price Crosses Below Two Hundred Day Moving Average – Here’s Why
Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report)'s share price passed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $15.95 and traded as low as $14.11. Reckitt Benckiser Group shares last traded at $14.13, with a volume of 733,330 shares
Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript
Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript
Reckitt beats its own targets and signals confidence in 2026 after year of strategic progress
Consumer health group delivers core growth ahead of medium-term guidance as emerging markets surge and Essential Home disposal completes Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB), the maker of Dettol, Nurofen and Durex, said it looks forward "with confidence" after a year in which its core business grew faster than its own medium-term targets, and promised to sustain that momentum into 2026. The company guided for Core Reckitt like-for-like (LFL) net revenue growth within its 4% to 5% medium-term range for 2026, despite flagging a weaker cold and flu season in the first quarter and a continued difficult trading environment in Europe.
Lysol Maker Reckitt Books Rise in Revenue, Boosted by Emerging Markets
The Lysol disinfectant maker's sales grew 5% on a like-for-like basis on year, Reckitt Benckiser said.
Reckitt to pay £1.6bn special dividend after Essential Home sale
Reckitt Benckiser Group PLC (LSE:RKT, XETRA:3RB) has unveiled plans to hand back about £1.6 billion to shareholders through a one-off special dividend, following the sale of its Essential Home business. The consumer goods group said it intends to pay a special dividend of 235 pence a share after completing the disposal of the division to Advent International, a deal announced at the end of December.
Reckitt Benckiser Group Plc. ADR (RBGLY) Focus On Emerging Markets: Growth Opportunities and Strategic Capabilities Discussion Transcript
Reckitt Benckiser Group Plc. ADR (RBGLY) Focus On Emerging Markets: Growth Opportunities and Strategic Capabilities Discussion Transcript
Reckitt steadies its course as bank lifts target
Reckitt Benckiser Group PLC's (LSE:RKT, ETR:3RB) turnaround may finally be gaining traction. RBC Capital Markets has raised its price target from £60 to £64 and reiterated an outperform rating, arguing that the consumer goods group is building a record of reliable mid-single-digit growth and improved execution under its “Fuel for Growth” plan.
Reckitt Benckiser Group Plc. ADR (RBGLY) Q3 2025 Sales Call Transcript
Reckitt Benckiser Group Plc. ADR (OTCPK:RBGLY) Q3 2025 Sales Call October 22, 2025 3:30 AM EDT Company Participants Nicholas Ashworth - Head of Investor Relations Kris Licht - CEO & Executive Director Shannon Eisenhardt - CFO & Executive Director Conference Call Participants Guillaume Gerard Delmas - UBS Investment Bank, Research Division Warren Ackerman - Barclays Bank PLC, Research Division David Hayes - Jefferies LLC, Research Division Celine Pannuti - JPMorgan Chase & Co, Research Division Jeremy Fialko - HSBC Global Investment Research Edward Lewis - Rothschild & Co Redburn, Research Division Rashad Kawan - Morgan Stanley, Research Division Tom Sykes - Deutsche Bank AG, Research Division Presentation Nicholas Ashworth Head of Investor Relations Good morning, everybody, and welcome to Reckitt's Q3 trading update.
